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Attention-deficit/hyperactivity disorder (ADHD) is a common, early-onset and enduring developmental disorder
whose underlying etiological and neurobiological processes are the current focus of major research. Research
strategies have made considerable effort in elucidating the complex genetic architecture of ADHD and indicate
various pathways from genotype to phenotype. Understanding ADHD as a neuropsychiatric disorder enabled to
investigate markers of neural activity as endophenotypes to better explain the link from gene to symptomatology
(the so-called imaging genetics approach). Overcoming the originally rather restrictive requirements for an
endophenotype, imaging genetics studies are supposed to offer a much more flexible and hypothesis-driven
approach towards the etiology of ADHD. Although 1) ADHD often persists into adulthood, thus remaining a
prevalent disorder, and 2) imaging genetics provides a promising research approach, a review on imaging genetics
in adult ADHD – as available for childhood ADHD (Durston 2010) – is lacking. In this review, therefore, findings from
the few available imaging genetics studies in adult ADHD will be summarized and complemented by relevant
findings from healthy controls and children with ADHD that are considered important for the adult ADHD imaging
genetics approach. The studies will be reviewed regarding implications for basic research and possible practical
applications. Imaging genetics studies in adult ADHD have the potential to further clarify pathophysiological
pathways and mechanisms, to derive new testable hypotheses, to investigate genetic interaction effects and to
partly influence practical applications. In combination with other research strategies, they can incrementally foster
the understanding of relevant processes in a more comprehensive way. Current limitations comprise the incapability to
discover new genes, a high genetic load in patients potentially obscuring the effect of single candidate genes, the
mostly unknown heritability of the endophenotype and the heterogeneous manifestation of ADHD.Introduction
Attention-deficit/hyperactivity disorder (ADHD) repre-
sents a common, early-onset and enduring neurodeve-
lopmental disorder with a worldwide-pooled prevalence
of 5.3% in childhood and adolescence [1]. In adulthood,
ADHD-related symptoms may still cause impairments
and its pooled prevalence still amounts to 2.5% [2,3], so
it cannot be regarded a mere transitional childhood dis-
order. Both childhood and adult ADHD have a large* Correspondence: thomas.dresler@med.uni-tuebingen.de
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reproduction in any medium, provided the oreconomic impact on society [4] and have been in a ma-
jor focus of research in the last decades (see [5,6]).
Research strategies have made great efforts in elucidat-
ing the complex genetic architecture of childhood and
adult ADHD [7,8]; association and linkage studies have
revealed relationships of specific candidate genes with
ADHD and with disorder-specific symptom scales, poin-
ting towards pathophysiologically relevant genetic influ-
ences. The understanding of ADHD as a neuropsychiatric
disorder (e.g., [9]) further enabled the investigation of the
influence of specific genetic variations on markers of neu-
ral activity to better explain the link from gene to disorder
and symptoms, respectively [10]. In such an imaging
genetics approach neuroimaging data are treated asLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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closely related to the underlying cellular and pathophysio-
logical processes than the symptomatic behavior or the
categorical diagnoses themselves. The pathway from gene
to behavior is complex and characterized by different
steps (see Figure one in [12]): variation in gene expression
results in differential availability of proteins, which are ne-
cessary for specific structural and functional properties of
neurons that make up neural units and circuits. The re-
sponse of these circuits can be measured using various
neuroimaging techniques such as functional magnetic res-
onance imaging (fMRI), positron emission tomography
(PET), functional near-infrared spectroscopy (NIRS), mag-
netoencephalography (MEG) and electroencephalography
(EEG). The first imaging genetics studies were published
around the millennium (e.g., [13]) when imaging methods
became more broadly available. Since then, the number of
publications on imaging genetics has increased consider-
ably and studies where applied to various neuropsychiatric
disorders and related (endo)phenotypes.
Although the endophenotype concept for neuropsychi-
atric disorders [14] was rather restrictive and axiomatic
when being first introduced (e.g., [11]), in recent years
notions for a reconceptualization have been proposed.
For example, Kendler and Neale [15] stress the necessity
of differentiating between mediational (i.e. the endophe-
notype mediates the relation from gene to disorder) and
liability index models (i.e. the endophenotype is risk-
indicating and may only be an epiphenomenon), thus
broadening the original framework. Furthermore, endo-
phenotypes and thus imaging data could reflect environ-
mental influences; it is also feasible to assume that some
genetic influences only affect the endophenotype while
others only affect the clinical symptoms [15]. Taken to-
gether, this illustrates that current concepts of (neuroim-
aging) endophenotypes may provide new insights into
the pathophysiological processes and mechanisms as
several influencing factors are considered and as the ori-
ginally rather restrictive requirements for an endophe-
notype do not have to be fulfilled. This allows a much
more flexible and hypothesis-driven approach towards
the etiology of ADHD. Yet, imaging genetics in ADHD
is still in its infancy and studies are scarce [16].
Although 1) ADHD often persists into adulthood, thus
remaining a prevalent disorder, and 2) imaging genetics
provides a promising research approach, a review on im-
aging genetics in adult ADHD – as available for child-
hood ADHD [17] – is lacking. In the present review, we
will first summarize the findings from the few available
imaging genetics studies in adult ADHD and subse-
quently discuss the various potentials and challenges in
pathophysiological research and clinical implications as-
suming a more flexible understanding of endopheno-
types [15].Review
Literature searches using available data bases (pubmed,
google scholar) were conducted to find imaging genetics
studies in adult samples of ADHD (till May 2013). Eight
studies (4 fMRI, 4 EEG) were then classified into two
categories, i.e. cognitive and affective-motivational ap-
proaches, depending on whether they applied cognitive
or emotional-motivational paradigms.a Although this
distinction is arbitrary and may not always be unambigu-
ous, it should help to better organize the available data.
Table 1 summarizes the reviewed studies and Table 2
provides information about the effects the gene variants
have.
Cognitive paradigms
Patients with childhood and adult ADHD show impair-
ments in different cognitive domains [18,19] which rep-
resent a core feature in ADHD-related psychopathology
(e.g., [5]). The available imaging genetics studies have
implemented different cognitive paradigms.
Go/NoGo paradigms
Continuous performance tasks (CPT, see [20]) involve
the combination of response execution (in Go trials) and
response inhibition processes (in NoGo trials) and thus
higher-order motor control and attention. In a series
of electroencephalographic (EEG) studies, our research
group has applied an OX version of the CPT in a large
sample of adult ADHD patients investigating the influ-
ence of several gene variants on behavioural and neural
parameters. In these studies, we derived a topographical
event-related potential (ERP) parameter, the so-called
NoGo anteriorization (NGA), which has been proposed
to reflect mechanisms of prefrontal response control.
Basically, the individual NGA is calculated as the dif-
ference between the mean area centroids of the P300
field maps for the Go and NoGo condition. In one study
[21], for two ADHD-associated gene variants within the
tryptophan hydroxylase 2 (TPH2) gene (i.e. rs4570625,
rs11178997) the risk alleles were associated with reduced
NGA in both patients and controls. On the behavioral
level, the expected pattern of lower performance in
ADHD was found. In a subsequent study, the dopamine
transporter (DAT, SLC6A3) gene was investigated. It had
been found that in adult ADHD – contrary to childhood
ADHD – the 9-repeat allelic variant of SLC6A3 repre-
sented the risk allele [22,23]. Therefore, we hypothesized
for our adult sample that the 9-repeat allele should be
associated with decreased prefrontal function. In line
with this hypothesis we found that – only in patients –
the 9-repeat allele was associated with a reduced NGA,
while there was no significant effect in the control group
[24]. Recently, we were able to show that – across
ADHD patients and controls – there was no main effect
Table 1 Studies on imaging genetics in adult ADHD
Authors Participants Paradigm Gene variant Imaging Imaging genetics results
Baehne et al. [21] 124 patients Go/NoGo task (CPT) TPH2 (G-allele polymorphism
in rs4570625, T-allele
polymorphism in rs11178997)
EEG (NGA) Reduced NGA in risk allele carriers in
ADHD and healthy controls
84 controls
Dresler et al. [24] 161 patients Go/NoGo task (CPT) SLC6A3 (3′ UTR VNTR) EEG (NGA) Reduced NGA in 9-repeat allele carriers
in the patients, no influence in healthy
controls109 controls
Fallgatter et al. [29] 216 patients Go/NoGo task (CPT) LPHN3 EEG (NGA) Reduced NGA in the LPHN3 high
risk group
Heinzel et al. [25] 181 patients Go/NoGo task (CPT) COMT (Val158Met), DRD4
(exon 3 VNTR)
EEG (NGA) Significant DRD4 × COMT interaction on
NGA (DRD4 no7R: inverted u-shape with
increasing COMT-dependent DA levels,
DRD4 7R: u-shape), no gene main
effects, no interaction with group
114 controls
Brown et al. [23] 52 patients Working memory (n-back) SLC6A3 (3′ UTR VNTR) fMRI Marginal reduced left mePFC signal in
9-repeat allele carriers in patients and
controls, marginal genotype-by-
diagnosis interaction in the SMA/dACC
(increased activation in 10-repeat allele
homozygous patients vs. controls)
38 controls
Brown et al. [30] 42 patients Multi-source interference
task
SLC6A3 (3′ UTR VNTR) fMRI Hypoactivation in 9-repeat allele
homozygous patients in the left dACC
Hoogman et al. [32] 63 patients Delay discounting task NOS1 exon 1f-VNTR fMRI SS-allele carriers demonstrate higher
ventral striatum activity in patients
41 controls
Hoogman et al. [34] 87 patients Delay discounting task SLC6A3 (3′UTR VNTR/intron 8
VNTR haplotype)
fMRI No significant effects of DAT1 haplotype
on striatal activity
77 controls
CPT, continuous performance test; DA, dopamine; dACC, dorsal anterior cingulate cortex; EEG, electroencephalography; fMRI, functional magnetic resonance
imaging; mePFC, medial prefrontal cortex; NGA, NoGo-anteriorisation; SMA, supplementary motor area; UTR, untranslated region; VNTR, variable number of
tandem repeats.
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methyl transferase [COMT] val158met polymorphism;
dopamine receptor D4, DRD4 variable number of tan-
dem repeats [VNTR]) on behavioral performance or the
NGA, but an interaction between the gene variants on
the investigated parameters [25]. Such gene-by-gene in-
teraction effects may offer new insights into the inter-
play of various genes at the physiological level. During
the last years, a rather unexpected genetic candidate
came into focus of ADHD research, i.e. common haplo-
type of the latrophilin 3 (LPHN3) gene that has been
found to be associated with the disorder in pedigrees
and population-based studies [26,27]. It has also been
shown to modulate dopaminergic neuron formation and
locomotor activity/impulsivity in zebrafish, whereby ef-
fects can be influenced by methylphenidate [28]. Given
this, we also found that having two risk alleles of the
LPHN3 gene was associated with a decreased NGA [29].
Working memory paradigms
In these tasks, subjects are required to maintain or ma-
nipulate information in memory to fulfil specific experi-
mental conditions. In an fMRI study, Brown et al. [23]
applied a sequential letter visual n-back task and investi-
gated whether task-specific activation contrasting 2- vs.0-back was influenced by group or DAT genotype. While
no differences emerged on the behavioral level, a mar-
ginal association of the DAT 9-allele with increased
task-related suppression in the left medial PFC and a
marginal genotype × diagnosis interaction in the dorsal
anterior cingulate cortex (dACC) was found. According
to the authors, the finding suggests that the task-related
suppression in the default mode network (DMN) might
act as an intermediate phenotype between DAT1 and
ADHD.
Interference paradigms
These tasks require subjects to ignore specific (task-ir-
relevant) information to perform the experimental con-
ditions correctly. In an ADHD group, Brown et al. [30]
investigated mediating effects of the DAT1 gene on dACC
function in a multi-source interference task (MSIT) and
found less activation in homozygous 10- as compared to
9-repeat allele carriers when confronted with response-
incongruent interfering stimuli.
Affective-motivational paradigms
In the emotional domain, ADHD patients also display
various disturbances [31]; however, these have so far
rarely been investigated in imaging genetics studies.
Table 2 Effects of gene variants
Gene variant Gene product Gene product
function
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COMT, Catechol-o-methyltransferase; DAT, dopamine transporter; NAA/Cr, N-acetyl aspartate/creatine; NO, nitric oxide; PFC, prefrontal cortex; UTR, untranslated
region; VNTR, variable number of tandem repeats.
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Hoogman et al. [32] applied a delay discounting task in
which subjects had to choose between hypothetical imme-
diate or delayed rewards. fMRI data indicated a generally
increased ventral striatal activity in controls vs. ADHD pa-
tients; however, across both groups homozygous carriers of
the short allele of the nitric oxide synthase (NOS1) gene
(for more information see [33]) exhibited increased activity
which – in the patients – was accompanied by higher im-
pulsivity. Therefore, the authors assume the NOS1 influ-
ence on ADHD to be mediated by its effect on impulsivity.
In another study, Hoogman et al. [34] investigated the influ-
ence of a DAT haplotype on ventral striatum activation dur-
ing reward anticipation. Here, besides the a priori expected
increased ventral striatal activity in controls vs. ADHD
patients, no effect of the haplotype could be discerned.
Paloyelis et al. [35] argued against a deficit in
anticipation-related neural activation in the ventral stri-
atum. Instead they suggested dysfunctional processing
of reward outcomes in adolescents with combined
ADHD subtype (ADHS-CT). They further highlighted
the role of genes influencing dopamine signaling in
reward-processing as a DAT haplotype was found to mo-
dulate striatal responsivity during incentive-predicting
stimuli. DAT 10/6-repeat allele homozygosity was associ-
ated with decreased reward-related anticipatory striatum
activity in the ADHD-CT on the one hand, but increasedneural activation in healthy controls on the other hand. In
how far these findings also apply to adults has yet to be
investigated.
Research on other endophenotypes and genes
As the number of available imaging genetics studies in
adult ADHD is limited so far, we will shortly refer to ex-
emplary findings in healthy subjects and children. Es-
pecially studies on emotional processing are promising.
Behavioral studies reveal that ADHD children are less ac-
curate in classifying emotional facial expressions [36-38].
On some measures they even tend to perform worse than
autistic children [39] and seem to be unaware of their
compromised social cognition [40]. These perceptual defi-
cits can interfere with executive functions [41] and are not
restricted to facial expressions, but occur in a similar way
for vocal emotions [36,37]. Behavioral studies in adult
ADHD indicate that deficits in judgment of facial expres-
sions persist to adulthood [31]. The neural correlates of
this disturbed perception of emotional signals as well as
their genetic origins, however, are largely unknown and
warrant further investigation.
Neuroimaging studies in healthy participants provided
evidence for distinct pathways for explicit versus impli-
cit processing of emotions in faces [42] and voices [43].
Studies on explicit processing of emotions in childhood
ADHD [44] revealed a hyperactivation of the amygdala
Dresler et al. Borderline Personality Disorder and Emotion Dysregulation 2014, 1:6 Page 5 of 9
http://www.bpded.com/content/1/1/6during such paradigms. This enhanced activation of the
amygdala in ADHD patients is in line with structural
findings [45] as well as with a reduction of dopamine re-
ceptors [46] in this brain area. Genetic imaging studies
in healthy subjects demonstrated that brain activation
during emotional processing can be strongly influenced
by the genotype of key enzymes of dopaminergic path-
ways including DRD4 [47] and DAT [48]. These genes
have been associated with an increased risk for ADHD
(for a review see [7,27]). In particular, the high-activity
genotype of COMT is a strong candidate for mediating
altered emotional perception in ADHD since it has been
shown to be linked to antisocial behavior in this pa-
tient group [49]. Similarly, recently described genes such
as the brain-expressed GTP-binding RAS-like 2 gene
DIRAS2 [50] and LPHN3 [27,49] have also been shown
to be associated with personality traits that predispose to
socially disruptive behavior. Further candidate genes de-
rived from imaging genetics studies in healthy adults that
might impact perception of emotional stimuli in ADHD
include the TPH2, which has been shown to modulate
amygdala activity to emotional stimuli (rs4570625 G-allele
polymorphism, [51]), as well as Stathmin 1 (STMN1), a
neuronal growth associated protein which is highly ex-
pressed in the amygdala that modulates the P300 in an
emotional Stroop task (rs182455 C-allele, [52]). Conside-
ring overlapping symptoms with borderline personality
disorder (BPD) [53], studying mechanisms related to emo-
tional dysregulation may clarify shared pathways.
Apart from dysfunctional emotional processes, other
endophenotypes need to be considered in further stud-
ies, e.g., neuropsychological deficits, such as measures of
attention, executive function and processing speed [54].
Furthermore, also other genes in the dopaminergic, sero-
tonergic, noradrenergic and neurotrophic system need
to be considered [7].
Discussion
So far, imaging genetics studies in adult ADHD are –
compared to other lines of ADHD research – rather
scarce and research is still at its beginning. Nonetheless,
the available findings provide an outlook on the poten-
tial chances of this research approach which – in com-
bination with complementary approaches – may help to
increase our knowledge about the pathophysiological
pathways in adult ADHD. Yet, several limitations need
to be considered as well (see below).
Promises
The imaging genetics approach provides an improved
insight into possible, important pathophysiological path-
ways and it allows deriving testable hypotheses that
promote a better understanding of the neurobiology of
normal and pathophysiologically altered behavior. Studiesreporting that gene variants influence neural markers in-
dependently of diagnostic status (e.g., [21,23,25,32]) hint
at common neural pathways in patients and controls.
Such influences are in line with a more continuous model
of ADHD phenotypes going beyond simple categorical
disorders. Assuming such a continuously distributed trait
in the population [55,56] – with ADHD being defined by
an arbitrary threshold on this trait – may allow to estimate
the individual risk for passing this threshold taking into
account several single candidate genes. Studies only show-
ing associations in ADHD patients, but not in healthy
controls (e.g., [24]), hint at more disorder-specific path-
ways that may influence brain activity – and therefore
clinically relevant behavior – independently of shared pro-
cesses. Here, the presence of specific gene variants may in-
dicate specific (neuropsychological) symptom dimensions,
e.g., neural impairment in executive functions.
Candidate genes that have been replicated empirically
in large-scale association studies (e.g., DAT) can be
tested regarding their functional impact in a hypothesis-
driven approach. These genetic findings indicate an in-
volvement of specific psychopathological pathways which
can be further investigated in imaging genetics studies:
For example, the association of the DAT 9-repeat allele
with adult ADHD led to our hypothesis that this allele –
which influences the frontal-striatal loop – may be associ-
ated with a concurrent less efficient prefrontal functioning
in our adult ADHD sample [24].
Imaging genetics has the potential to be used in a
translational manner, thus allowing basic findings to in-
fluence practical applications. If specific gene variants
are highly associated with altered brain activation in spe-
cific cognitive or emotional domains, a more tailored
pharmacological or psychotherapeutic intervention can be
chosen, thus offering new treatment targets [57]. Mattay
et al. [58] found that COMT val/val carriers (i.e. carriers
of the high enzyme activity variant putatively showing
suboptimal prefrontal function at baseline) displayed more
efficient prefrontal function in a working memory task
after an amphetamine challenge, whereas in met/met car-
riers counterproductive effects were observed at high
working memory loads. Studying schizophrenic patients,
Ehlis et al. [59] found the val/val allele to be associated
with lower performance and a reduced NGA; furthermore,
they showed that patients responded better to typical or
atypical antipsychotics depending on their NGA values be-
fore treatment [60]. Using and combining such knowledge
may help to more carefully adjust treatment regimes and
to reduce side effects.
Complex interactive effects of several genes with indi-
vidually small impact [61] have been suggested to under-
lie ADHD. The increasing number of large-scale studies
will enable to investigate putative gene-by-gene interac-
tions and their influence on ADHD-related behavior and
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factors contribute to ADHD; however, little is known
about precise gene-by-environment interactions on the
neural level. Therefore, gene-by-environment interac-
tions could be a further target in such studies augment-
ing the data from behavioral studies and helping to
clarify existing inconsistencies [62]. Integrating imaging
genetics to investigate these interactions (for an over-
view see [63]) and distinct endophenotypes can lead to
more precise statements concerning direct versus indir-
ect effects of genes or environment on ADHD.
Imaging genetics is one element that in combination
with other – also distant – research strategies (e.g., in vivo
and in vitro investigations, animal models, combined
PET-fMRI measurements) helps to identify important
pathophysiological mechanisms. For example, the research
on the risk haplotype in the LPHN3 gene originated from
pedigree linkage studies in a Columbian genetic isolate
[26] and was subsequently complemented by association
samples in Caucasian samples [27,64]. This convinced us
to stratify our ADHD sample regarding this haplotype and
we indeed found a reduced prefrontal functioning in the
subgroup with two risk alleles [29]. At the same time, a
study investigating the ortholog lphn3.1 in the zebrafish
revealed that loss of its function resulted in misplaced di-
encephalic dopaminergic neurons and hyperactive and im-
pulsive swimming behaviour; furthermore, this could be
reversed by the common ADHD drugs methylphenidate
and atomoxetine [28]. These findings fit with disturbances
in the development of the dopaminergic system being in-
fluenced by this protein/receptor complex whose actual
function is not well understood. As LPHN3 is not a direct
key player in the dopaminergic system, its functional im-
pact has to be further investigated. Here, imaging genetics
may help to identify functional processes and underlying
brain networks that are affected by gene variants and
might link LPHN3 (albeit indirectly) to dopaminergic
pathways.
Current limitations of the reviewed studies
Up to now, most studies in imaging genetics, especially
in clinical research, lack large sample sizes. Several fac-
tors may contribute to this: e.g., patient recruitment
problems or financial issues. Moreover, no longitudinal
studies investigating the impact of gene variants across a
specific time-span are available. Particularly, the different
association of DAT polymorphism with ADHD in child-
hood vs. adulthood should be further elucidated by lon-
gitudinal research.
Although these candidate gene studies provide import-
ant information in the context of a clear functional hy-
pothesis, they are unable to discover new genes or their
combinations [65]. A genome-wide approach could, but
is not feasible in imaging genetics. Furthermore, onlyinvestigating single genes might be a restricted perspec-
tive on the complexity, as larger influences of non-
candidate genes could be missed.
The imaging genetics approach might be problematic,
as patients are prone to disorder-related confounds and
hence carry a high genetic load which also includes low-
frequency genes (see Box 7 in [66]). This may obscure
the effect of single common candidate genes which are
the main target of the articles. The investigation of ADHD
genes in larger healthy samples could help to assess and
avoid these confounds.
Often, the question remains whether the applied im-
aging paradigms are in fact heritable. To date, a few
studies already indicate heritability of the brain activa-
tion during working memory [67,68] and inhibition [69]
which supports the assumption of a heritable endophe-
notype; however, for most of the paradigms heritability
has not been tested.
As dopaminergic candidate genes have been exten-
sively investigated in molecular genetics studies [7,70],
imaging genetics studies should more specifically target
these to further elucidate intermediate neurobiological
processes.
ADHD shows a considerable overlap in clinical symp-
toms (e.g., emotional dysregulation) with BPD. High
genetic correlations for these disorders support the hy-
pothesis that ADHD in childhood might even be a pre-
cursor of BPD in adulthood [71]. Thus, future imaging
genetics studies should include patient samples of both
disorders to clarify whether identified endophenotypes
are specific or reflect a common pathway of these disor-
ders that result in impaired emotion regulation.”
Another aspect which is often not considered in cur-
rent research literature on ADHD is its rather hetero-
geneous manifestation. Refining research in this respect
might reduce contradictory results and simultaneously
enhance comparability between studies. Also in this con-
text, imaging genetics could be one approach to define
ADHD subtypes that are more strongly related to differ-
ences in underlying neurobiology than current “clinical”
diagnostic classifications. Some studies focusing on DSM-
IV subtypes (inattentive, hyperactive, combined type) did
not provide any significant effects [72,73], while others re-
vealed age-specific and persistent as well as cross-subtype
and subtype-specific gene influences [74]. Such findings
highlight the need to control for factors such as age or co-
morbid symptoms in imaging genetics studies. Beyond
that, the so far scarce evidence of a genetic basis for
DSM-IV subtypes needs to be further substantiated. Alter-
natively, besides diagnostic subtypes, further neuropsycho-
logically based models could be taken into account to
cope with the heterogeneity in ADHD. For example, the
dual pathway model [75], subsequently refined to a triple
pathway model [76], suggests ADHD-CT to be either a
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in turn are suggested to be based on different pathways in
the dopamine system. Even though current models still
differ in many ways and could be further corroborated,
they share the notion of ADHD as a heterogeneous dis-
order including different subtypes based on alterations in
distinct neural pathways. This common view should be
considered when focusing on gene moderating or mediat-
ing effects on brain functioning in ADHD with the longer-
term objective to diminish inconclusive or contradictory
results.
Limitations of the review
The review is based on only a few studies which prevents
drawing strong unequivocal conclusions. These studies
are also rather diverse with regards to paradigm, endophe-
noype measurement and investigated candidate genes.
Conclusion
Taken together, current literature on the genetics of
ADHD is not conclusive. Here, imaging genetic studies
could come into play and lead to new insights regarding
the complex and diverse pathways from the level of gen-
etic vulnerability to overt clinical symptoms. Also, pres-
ently, the reported research findings are not directly
applicable in clinical practice for adult ADHD (diag-
nostics, treatment, therapy) which is an aspiration for
the near future. As in 30% of ADHD patients stimu-
lant treatments do not lead to symptom improvements
[77], further research on pharmacogenetics is required.
Longterm-studies integrating neuropsychological and neu-
roimaging methods may advance our comprehension of
underlying mechanisms in drug action. Up till now, only
one study has combined functional near-infrared spectros-
copy imaging and possibly moderating genotypes in a
treatment study using methylphenidate [78]. So, in re-
search on effective and long-term stable treatment, differ-
ent ADHD subtypes should be taken into account using
imaging genetics.
Endnote
aOne study [78] was not integrated as both adult and
adolescent ADHD patients were investigated, but not
analyzed separately.
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